About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
3,076
By Phase
PHASE2: 4PHASE3: 2
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06785454Lead Sponsor
A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension
PHASE2Active, not recruiting
48 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2026
NCT06150924Lead Sponsor
Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria
PHASE2Completed
60 participants
Started: Dec 14, 2023 · Completed: Apr 23, 2025
NCT06153693Lead Sponsor
Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension
PHASE3Completed
1,083 participants
Started: Nov 22, 2023 · Completed: Jan 24, 2025
NCT05968430Lead Sponsor
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
PHASE3Active, not recruiting
1,400 participants
Started: Jul 14, 2023 · Completed: Dec 31, 2026
NCT05769608Lead Sponsor
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen
PHASE2Completed
285 participants
Started: Mar 13, 2023 · Completed: Jan 15, 2025
Locations (1)
Headquarters
Radnor, PA, United States
Map
Loading map...